Skip to main content

Advertisement

Table 1 Clinicopathological characteristics for the 206 ovarian carcinoma patients

From: Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas

  Number of patients (%)  
  HGSC EC MC CCC  
  (n = 94) (n = 46) (n = 29) (n = 37) P value
Patient age 0.457
 Mean 64 62 60 65  
 Range 22–88 25–83 30–82 42–84
Overall Survival 0.082
 0-2y 7 (7) 3 (7) 6 (21) 5 (14)  
 2-5y 26 (28) 9 (20) 3 (10) 10 (27)
 5-10y 28 (30) 7 (15) 7 (24) 8 (22)
 >10y 33 (35) 27 (59) 13 (45) 14 (38)
Cause of death 0.001
 Ovarian carcinoma 53 (56) 7 (15) 5 (17) 19 (51)  
 Other cancer 8 (9) 6 (13) 4 (14) 2 (5)
 Other 10 (11) 10 (22) 8 (28) 6 (16)
 Alive 15 (16) 17 (37) 7 (24) 8 (22)
 Not available 8 (9) 6 (13) 5 (17) 2 (5)
Stage 0.005
 I 51 (54) 32 (70) 22 (76) 31 (84)  
 II 43 (46) 13 (28) 7 (24) 6 (16)  
Tumor grade EC NA
 FIGO grade I NA 11 (24) NA NA  
 FIGO grade II NA 27 (59) NA NA
 FIGO grade III NA 8 (17) NA NA
Dualistic model 0.643
 Type I 0 (0) 46 (100) 29 (100) 37 (100)  
 Type II 94(100) 0 (0) 0 (0) 0 (0)
CA125 0.106
 <35 17 (18) 13 (28) 10 (35) 14 (38)  
 35–65 17 (18) 7 (15) 8 (28) 8 (22)
 >65 60 (64) 25 (54) 11 (38) 15 (41)
 Not available 0 (0) 1 (2) 0 (0) 0 (0)
Ploidy 0.168
 Near diploid 22 (23) 17 (37) 7 (24) 5 (14)  
 Aneuploid 69 (73) 26 (57) 19 (66) 30 (81)
 Not available 3 (3) 3 (7) 3 (10) 2 (5)
Chemotherapy 0.212
 Yes 91 (97) 42 (91) 27 (93) 37 (100)  
 No 0 (0) 0 (0) 0 (0) 0 (0)
 Not available 3 (3) 4(9) 2 (7) 0 (0)